Valeant Increases Offer for Obagi Medical Products After Merz Pharma Bid
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 4 (Table of Contents)
Published: 5 Apr-2013
DOI: 10.3833/pdr.v2013.i4.1917 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Valeant Pharmaceuticals International has made a sweetened offer to acquire Obagi Medical Products, a California-based developer of physician-dispensed skincare systems, for US$24 per share...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS